Author | : Jack A. Roth,James D. Cox,Waun Ki Hong |
Publisher | : John Wiley & Sons |
Release Date | : 2011-08-26 |
ISBN 10 | : 1444358669 |
Pages | : 480 pages |
Lung cancer is a major cause of cancer-related deaths in men and women. However, since the first edition of Lung Cancer was published 14 years ago, rapid progress in the biology, prevention, diagnosis, and treatment of the disease has been made.
Author | : Karen L. Reckamp |
Publisher | : Springer |
Release Date | : 2016-08-17 |
ISBN 10 | : 3319403893 |
Pages | : 322 pages |
This book describes the molecular mechanisms of lung cancer development and progression that determine therapeutic interventions in the era of genomics, when the rapid evolution in lung cancer diagnosis and treatment necessitates critical review of new results to integrate advances into practice. The text opens with background and emerging information regarding the molecular biology of lung cancer pathogenesis. Updated results regarding lung cancer prevention and screening are discussed, followed by chapters on diagnostic techniques and pathological evaluation. This leads on to a detailed presentation of treatment modalities, from surgery and radiation therapy to standard chemotherapy and targeted agents. The coverage includes resistance to therapy and the emergence of immunotherapy for lung cancer; in addition, the current evidence in respect of small cell lung cancer is summarized. The book presents insights from experts across disciplines to emphasize the importance of collaborative care. Advances in our understanding of issues in geriatric oncology and palliative care complete the comprehensive discussion of lung cancer.
Author | : Heine Hansen |
Publisher | : CRC Press |
Release Date | : 2008-03-17 |
ISBN 10 | : 9780415385107 |
Pages | : 480 pages |
Textbook of Lung Cancer, 2nd edition, published in association with the European Society of Medical Oncology, is a comprehensive and multidisciplinary text, which examines all aspects of this disease, with contributions from a multinational team of authors on etiology, epidemiology, molecular biology, pathology, smoking, detection and management, clinical features, staging and prognostic factors, surgery, radiotherapy and chemotherapy. It provides essential information and guidance for specialist trainees in oncology, and for the many physicians and specialists involved in the field of lung cancer.
Author | : Mary O'Brien,Benjamin Besse |
Publisher | : Karger Medical and Scientific Publishers |
Release Date | : 2016-08-22 |
ISBN 10 | : 1910797197 |
Pages | : 86 pages |
Rapid developments in the classification, screening and treatment of non-small-cell lung cancer (NSCLC) are improving outcomes for patients with the disease. This insightful guide is designed to bring you up to speed with recent advances, including: • the latest CT-based screening and interval growth imaging techniques • proposed changes to the TNM classification system • the increasing trend for minimally invasive and lung-sparing surgery • stereotactic radiation for early-stage tumors • new targeted therapies • breakthroughs in personalized medicine. Today's developments will change tomorrow's standards of care. 'Fast Facts: Non-Small-Cell Lung Cancer' is important reading for all health professionals and medical trainees working in this fast-moving area.
Author | : Alba Fabiola Costa Torres |
Publisher | : BoD – Books on Demand |
Release Date | : 2018-10-31 |
ISBN 10 | : 1789843499 |
Pages | : 204 pages |
Among the deadliest type of cancers, lung cancer faces several challenges in diagnosis and treatment: late diagnosis and misdiagnosis, inadequate tumor sampling, and resistance development to current therapies, among others. Together with advances in the understanding of molecular features, factors, and mechanisms involved in initiation and tumor progression, important improvements have occurred in diagnostics and therapeutics in the shape of advances in molecular genotyping, procedures for sampling, new potential, and less invasive sources of samples for the diagnosis and development of new targeted therapies. The aim of this book is to provide an exciting read on strategies in the diagnosis and therapy of lung cancer.
Author | : Himender K. Makker |
Publisher | : Oxford University Press, USA |
Release Date | : 2018-11-22 |
ISBN 10 | : 0198813031 |
Pages | : 312 pages |
Part of the Oxford Case Histories series, this book contains 40 real-life clinical cases to demonstrate the management of lung cancer built on evidence-based recommended practice. Covering both commonly occurring presentations of lung cancer and particularly challenging problems, the Oxford Cases in Lung Cancer provides a multi-disciplinary approach, written by specialists in respiratory medicine, oncology, pathology, radiology, thoracic surgery, and palliative care.
Author | : National Cancer Institute (U.S.). Lung Cancer Progress Review Group |
Publisher | : N.A |
Release Date | : 2001 |
ISBN 10 | : |
Pages | : 54 pages |
Author | : N.A |
Publisher | : N.A |
Release Date | : 1998 |
ISBN 10 | : |
Pages | : 18 pages |
Author | : Robert M. Cook,York E. Miller |
Publisher | : N.A |
Release Date | : 1996 |
ISBN 10 | : |
Pages | : 74 pages |
Author | : John D. Minna |
Publisher | : N.A |
Release Date | : 1988 |
ISBN 10 | : |
Pages | : 3 pages |
Author | : Christian Manegold |
Publisher | : N.A |
Release Date | : 2010 |
ISBN 10 | : 9783837412567 |
Pages | : 190 pages |
Author | : Lynn T. Tanoue,Frank C Detterbeck |
Publisher | : Elsevier Health Sciences |
Release Date | : 2018-05-30 |
ISBN 10 | : 0323496067 |
Pages | : 350 pages |
Get a quick, expert overview of the many key facets of lung cancer evaluation and management with this concise, practical resource by Drs. Lynn T. Tanoue and Frank Detterbeck. This easy-to-read reference presents a summary of today’s best evidence-based approaches to diagnosis and management in this critical area. Covers diagnosis and evaluation, treatment considerations, and comprehensive care options for patients with lung cancer. Provides insight on evidence for today’s best practices, as well as future directions in the field. Consolidates today’s evidence-based information on the clinical aspects of lung cancer into one convenient resource.